PRGO (Perrigo Co) Margin of Safety % (DCF Earnings Based): N/A (As of Jun. 25, 2026)


PRGO Perrigo Co PLC PRGO
44 GF Score
Price $9.62
GF Value $25.00
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Perrigo Co Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Perrigo Co's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.


PRGO vs AMLX, HROW, ANIP: Margin of Safety % (DCF Earnings Based) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Perrigo Co's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Perrigo Co Margin of Safety % (DCF Earnings Based) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Perrigo Co's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Perrigo Co's Margin of Safety % (DCF Earnings Based) falls into.


PRGO
44GF Score
Perrigo Co PLC PRGO
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Perrigo Co (PRGO) Overvalued in 2026?

Based on GuruFocus' analysis, Perrigo Co stock appears to be undervalued. The current stock price of $9.62 is trading 61.5% below its estimated GF Value™ of $25.00. GuruFocus considers Perrigo Co to be Possible Value Trap.

Key valuation signals for PRGO:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: $25.00 vs. price of $9.62 (61.5% below fair value)
  • GF Score™: 44/100 with 4 warning signs

No single metric tells the full story. See the PRGO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Perrigo Co Business Description

Address The Sharp Building, Hogan Place, Dublin, IRL, D02 TY74
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo has divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two-thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.
44GF Score

Get the complete analysis for PRGO

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$9.62
Price
$25.00
GF Value